Osaic Holdings’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Other funds holding ALDX
KCM
VCM
KCM
6CM
Osaic Holdings's ALDX Position: Q1 2026 in Review
Osaic Holdings sold out of Aldeyra Therapeutics (ALDX) in Q1 2026, closing a stake of 40 shares — an estimated $207 sold.
Osaic Holdings first reported a position in ALDX in Q2 2020 and held it in 23 quarters. The position peaked at $309K in Q3 2023. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.
- Osaic Holdings reported no remaining Aldeyra Therapeutics position as of Q1 2026 after selling out during the quarter.
- Osaic Holdings sold 40 Aldeyra Therapeutics shares in Q1 2026, an estimated $207.
- Osaic Holdings first reported a position in Aldeyra Therapeutics in Q2 2020 and held it in 23 quarters.
- Osaic Holdings's Aldeyra Therapeutics position peaked at $309K in Q3 2023.
- 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.